In the United States, the Food and Drug Administration (FDA) serves as the primary regulatory authority overseeing the importation and distribution of pharmaceutical products. The FDA enforces the Federal Food, Drug, and Cosmetic Act (FD&C Act), which sets forth the legal requirements for drug products entering the U.S. market. This includes ensuring that imported drugs meet standards for quality, safety, and effectiveness.
Key legislation governing pharmaceutical imports includes the FD&C Act, which outlines the procedures for drug registration, labeling, and approval. The FDA's Regulatory Procedures Manual provides detailed guidance on import operations and actions, ensuring that imported drugs comply with U.S. regulations.
The marketing authorization pathway for Indian generics involves obtaining FDA approval, which requires demonstrating that the drug is safe and effective for its intended use. This process includes submitting an Abbreviated New Drug Application (ANDA) that provides evidence of bioequivalence to the reference listed drug. The FDA reviews these applications to ensure that imported generics meet the necessary standards before they can be marketed in the U.S.
